miR-6076 targets BCL6 in SH-SY5Y cells to regulate amyloid-β-induced neuronal damage

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Amyloid-beta (Aβ) is a key factor in Alzheimer's disease (AD) pathogenesis.
• Understanding the molecular mechanisms of Aβ-induced neuronal damage is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the role of miR-6076 in Aβ_1-42-induced neuronal damage.
• To identify the molecular targets and pathways regulated by miR-6076 in the context of AD.

Main Methods:

• Establishment of an Aβ_1-42-induced neuronal damage model using SH-SY5Y cells.
• Quantitative real-time PCR (qRT-PCR) to assess miR-6076 expression.
• miR-6076 inhibition and B-cell lymphoma 6 (BCL6) overexpression experiments.
• Dual-luciferase reporter assay to confirm BCL6 as a direct target of miR-6076.
• Assessment of apoptosis levels and cell viability.

Main Results:

• miR-6076 was significantly upregulated in Aβ_1-42-treated neuronal cells.
• Inhibition of miR-6076 reduced p-Tau and apoptosis levels, and increased cell viability.
• BCL6 was identified as a direct target of miR-6076.
• BCL6 overexpression reversed the detrimental effects of Aβ_1-42 on neuronal cells.

Conclusions:

• Down-regulation of miR-6076 can attenuate Aβ_1-42-induced neuronal damage.
• The miR-6076/BCL6 axis plays a critical role in neuronal protection against Aβ toxicity.
• Targeting miR-6076 presents a potential therapeutic avenue for Alzheimer's disease.